What is Collegium Pharmaceutical, Inc.'s revenue?

Collegium Pharmaceutical, Inc. (COLL) generated $796.3M in revenue over the trailing twelve months, up 19.9% year over year.

Is Collegium Pharmaceutical, Inc. profitable?

Collegium Pharmaceutical, Inc. reported $74.9M in net income over the trailing twelve months, a 9.4% net margin.

What are Collegium Pharmaceutical, Inc.'s profit margins?

Gross margin is 60.7% and operating margin is 23.7%, with a 9.4% net margin.

What is Collegium Pharmaceutical, Inc.'s earnings per share?

Collegium Pharmaceutical, Inc.'s diluted EPS over the trailing twelve months is $2.04.

Where does Collegium Pharmaceutical, Inc.'s income statement data come from?

Every line is extracted from Collegium Pharmaceutical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Collegium Pharmaceutical, Inc. COLL Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$780.57M+23.6%	$631.45M+11.4%	$566.77M+22.2%	$463.93M+67.6%
Total cost of revenue	$317.31M+24.9%	$254.11M+5.6%	$240.6M-5.4%	$254.45M+102%
Gross profit	$463.26M+22.8%	$377.34M+15.7%	$326.17M+55.7%	$209.49M+39.1%
Gross margin	59.3%-0.4pp	59.8%+2.2pp	57.5%+12.4pp	45.2%-9.2pp
Selling, general and administrative	$284.8M+35.4%	$210.36M+32.1%	$159.21M-7.5%	$172.19M+44.7%
Other operating expenses	$283.62M+36.7%	$207.45M+30.3%	$159.21M-9.6%	$176.17M+32.5%
Total operating expenses	$283.62M+36.7%	$207.45M+30.3%	$159.21M-9.6%	$176.17M+32.5%
Operating income	$179.64M+5.7%	$169.9M+1.8%	$166.96M+401%	$33.32M+89.0%
Operating margin	23%-3.9pp	26.9%-2.6pp	29.5%+22.3pp	7.2%+0.8pp
Interest expense	$82.31M+11.3%	$73.97M-11.2%	$83.34M+31.8%	$63.21M+201%
Interest income	$11.29M-19.2%	$13.98M-10.5%	$15.62M+1,391%	$1.05M+8,625%
Income before income taxes	$92.62M-6.0%	$98.57M+30.2%	$75.73M+363%	-$28.85M-755%
Income tax expense	$29.75M+1.3%	$29.38M+6.5%	$27.58M+817%	-$3.85M+94.9%
Net income	$62.87M-9.1%	$69.19M+43.7%	$48.16M+293%	-$25M-135%
Net margin	8.1%-2.9pp	11%+2.5pp	8.5%+13.9pp	-5.4%-31.2pp
Diluted earnings per share	$1.71-8.1%	$1.86+57.6%	$1.18+259%	-$0.74-144%
Basic earnings per share	$2.00-6.5%	$2.14+45.6%	$1.47+299%	-$0.74-137%
Weighted-average shares, diluted	151.4M-6.6%	162.1M+1.0%	160.5M+18.2%	135.8M-11.1%
Weighted-average shares, basic	126.8M-1.8%	129.1M-4.4%	135M-0.2%	135.3M-3.2%
Amortization of capitalized software and acquired intangible assets	——	$165.3M+13.4%	$145.76M—	——
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1	-$1.18M+59.4%	-$2.91M—	$0—	——
Net interest and investment income (loss)	$11.29M-19.2%	$13.98M-10.5%	$15.62M+1,391%	$1.05M+8,625%
Revenue From Contract With Customer Excluding Assessed Tax	$780.57M+23.6%	$631.45M+11.4%	$566.77M+22.2%	$463.93M+67.6%
EBIT	$179.64M+5.7%	$169.9M+1.8%	$166.96M+401%	$33.32M+89.0%
EBITDA	$239.29M-29.4%	$339.06M+7.2%	$316.22M+143%	$129.98M+50.2%
EBITDA	$239.29M-29.4%	$339.06M+7.2%	$316.22M+143%	$129.98M+50.2%
EBITDA margin	30.7%-23.0pp	53.7%-2.1pp	55.8%+27.8pp	28%-3.2pp
EBIT	$179.64M+5.7%	$169.9M+1.8%	$166.96M+401%	$33.32M+89.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Collegium Pharmaceutical, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s revenue?: Collegium Pharmaceutical, Inc. (COLL) generated $796.3M in revenue over the trailing twelve months, up 19.9% year over year.
Is Collegium Pharmaceutical, Inc. profitable?: Collegium Pharmaceutical, Inc. reported $74.9M in net income over the trailing twelve months, a 9.4% net margin.
What are Collegium Pharmaceutical, Inc.'s profit margins?: Gross margin is 60.7% and operating margin is 23.7%, with a 9.4% net margin.
What is Collegium Pharmaceutical, Inc.'s earnings per share?: Collegium Pharmaceutical, Inc.'s diluted EPS over the trailing twelve months is $2.04.
Where does Collegium Pharmaceutical, Inc.'s income statement data come from?: Every line is extracted from Collegium Pharmaceutical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.